The clocks may be ticking for stroke patients, but thanks to a groundbreaking new guideline from NICE, the NHS has just got a digital lifeline. The National Institute for Health and Care Excellence (NICE) has given its seal of approval to AI-derived software that can speed up diagnosis, potentially saving precious minutes – and lives.
The AI-powered tools use medical images, such as CT scans, to quickly identify areas of the brain affected by either an ischaemic stroke (caused by a blood clot) or a haemorrhagic stroke (caused by bleeding). By analysing these images rapidly, the software helps clinicians make quicker decisions about treatment. It's a critical step in the right direction, as time is of the essence when it comes to stroke care – every minute lost can lead to long-term disability or even death.
For those suffering from ischaemic strokes, drugs that break down blood clots (thrombolysis) or mechanical removal are most effective within a narrow window following symptom onset. By accelerating diagnosis with AI, more patients may receive these life-saving interventions in time. The new NICE recommendations highlight the potential for AI to boost efficiency in emergency departments and specialist stroke units.
While the software does not replace medical professionals' expertise, it acts as a valuable aid, flagging urgent findings and assisting in prioritising cases. This integration of technology aims to support – rather than supersede – clinical judgment. The NICE evaluation process has deemed the software clinically effective and cost-effective for adults with suspected acute ischaemic stroke or haemorrhagic stroke undergoing specific scans.
The implications for the NHS are significant, with approximately 100,000 strokes occurring in the UK each year (according to the Stroke Association). By streamlining stroke pathways, the technology could help standardise care and address variations in quality. It's a positive step towards improving diagnosis and treatment speed – and ultimately, patient outcomes.
Source: NeuroNews International